BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15868923)

  • 1. A potential for tissue restrictive gene therapy in renal cell carcinoma using MN/CA IX promoter.
    Ou YC; Gardner TA; Kao C; Zhau HE; Chung LW
    Anticancer Res; 2005; 25(2A):881-6. PubMed ID: 15868923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MN/CAIX gene expression in renal cell carcinoma detected by RT-PCR].
    Jiang YD; Zheng SB; Wang ZH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):925-7. PubMed ID: 15321764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of carbonic anhydrase IX gene expression in renal cell carcinoma with reverse transcription-PCR].
    Jiang YD; Zheng SB; Wang ZH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):99-101. PubMed ID: 14724112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
    Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MN/CA IX antigen as a potential target for renal cell carcinoma].
    Uemura H; Cho M; Nakagawa Y; Shimizu K; Yoshikawa M; Kim S; Hirao Y
    Hinyokika Kiyo; 2000 Oct; 46(10):745-8. PubMed ID: 11215204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma.
    Grabmaier K; A de Weijert MC; Verhaegh GW; Schalken JA; Oosterwijk E
    Oncogene; 2004 Jul; 23(33):5624-31. PubMed ID: 15184875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma.
    Ashida S; Nishimori I; Tanimura M; Onishi S; Shuin T
    J Cancer Res Clin Oncol; 2002 Oct; 128(10):561-8. PubMed ID: 12384800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
    Nakagawa Y; Uemura H; Shimizu K; Cho M; Yoshikawa M; Hirao Y; Yoshikawa K
    Hinyokika Kiyo; 2001 Nov; 47(11):809-14. PubMed ID: 11771176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antigen specific cellular immunity by vaccination with peptides from MN/CA IX in renal cell carcinoma.
    Shimizu K; Uemura H; Yoshikawa M; Yoshida K; Hirao Y; Iwashima K; Saga S; Yoshikawa K
    Oncol Rep; 2003; 10(5):1307-11. PubMed ID: 12883698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
    Papworth K; Sandlund J; Grankvist K; Ljungberg B; Rasmuson T
    Anticancer Res; 2010 Jul; 30(7):2953-7. PubMed ID: 20683038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation.
    Uemura H; Nakagawa Y; Iwai A; Okajima E; Okajima E; Yoshikawa K; Hirao Y
    Aktuelle Urol; 2003 Jul; 34(4):270-2. PubMed ID: 14566683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
    Li G; Passebosc-Faure K; Lambert C; Gentil-Perret A; Blanc F; Oosterwijk E; Mosnier JF; Genin C; Tostain J
    Clin Cancer Res; 2001 Jan; 7(1):89-92. PubMed ID: 11205923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.
    Lim HY; Ahn M; Chung HC; Gardner TA; Kao C; Lee SJ; Kim SJ
    Cancer Gene Ther; 2004 Aug; 11(8):532-8. PubMed ID: 15167900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of MN/CAIX in the diagnosis of renal cell carcinoma].
    Jiang YD; Ren F; Zheng SB
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):412-4. PubMed ID: 22445996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.
    Bismar TA; Bianco FJ; Zhang H; Li X; Sarkar FH; Sakr WA; Grignon DJ; Che M
    Pathology; 2003 Dec; 35(6):513-7. PubMed ID: 14660102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular detection of circulating cancer cells in patients with renal cell carcinoma].
    Uemura H
    Hinyokika Kiyo; 1999 Aug; 45(8):571-5. PubMed ID: 10500965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High cell density induces expression from the carbonic anhydrase 9 promoter.
    Kaluzová M; Kaluz S; Stanbridge EJ
    Biotechniques; 2004 Feb; 36(2):228-30, 232, 234. PubMed ID: 14989086
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene.
    Hernández JM; Bui MH; Han KR; Mukouyama H; Freitas DG; Nguyen D; Caliliw R; Shintaku PI; Paik SH; Tso CL; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 May; 9(5):1906-16. PubMed ID: 12738749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of MN/CA9 gene expression in identifying malignant solid renal tumors.
    Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J
    Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.